ZTS
Zoetis Inc.
NYQ
$76.39
-1.17
(-1.51%)
Deep pullback · -2.64σ
Hot zone
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$32.0B
P/E ttm
12.5
Fwd P/E
10.3
Beta
0.86
Day range
$76.39
52w range
$72.38 – $132.49
Avg vol
5.8M
RSI(2)
1.9
ROE
67.7%
Net mgn
28.0%
FCF mgn
18.7%
Debt/Eq
2.86
Div yld
278.00%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earn
2026-08-04
Matrix setup grades
Long
C
score 37 · tech 37 / 80 · support 0 / 20
KC2 lower, -2.38 ATR from EMA21 · hammer
- · KC2 lower stretch — standard mean-reversion tier
- · Hammer candle — long lower wick rejection
- · Counter-trend long in breakout_down
Short
—
score 16 · tech 16 / 80 · support 0 / 20
below KC1 upper, -2.38 ATR from EMA21 · no notable pattern
- · Aligned with breakout_down (strong tailwind)
Options · swing
See more →
CALL
$170
2026-07-17
$1.60
PUT
$65
2026-07-17
$0.64
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-05-07
- EPS (act / est)
- 1.42 / 1.54
- Surprise
- -7.6%
- Next report
- 2026-08-04
About
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and …